Location: France, Ile-de-France, Marly-le-Roi
Mentions in press and media 2
| Date | Title | Description |
| 27.09.2023 | SeaBeLife secures €1.2M to develop drug candidates intended to block cell necrosis | French biotech firm SeaBeLife has raised €1.2 million in additional seed funding to fund the further development of its drug candidates for acute liver disease and eye disorders as well as allow it to expand its team. The company intends to... |
| 28.03.2023 | ATANIS Biotech completes capital increase to improve the diagnosis of allergies |